Raymond James & Associates’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$6.81M Sell
463,504
-777,405
-63% -$11.4M ﹤0.01% 1443
2024
Q2
$17.9M Buy
1,240,909
+28,436
+2% +$410K 0.01% 833
2024
Q1
$19.7M Sell
1,212,473
-2,059
-0.2% -$33.5K 0.01% 783
2023
Q4
$18.1M Buy
1,214,532
+199,238
+20% +$2.97M 0.01% 780
2023
Q3
$11.4M Buy
1,015,294
+688,779
+211% +$7.74M 0.01% 965
2023
Q2
$3.28M Buy
326,515
+251,708
+336% +$2.53M ﹤0.01% 1754
2023
Q1
$703K Buy
74,807
+4,677
+7% +$44K ﹤0.01% 2679
2022
Q4
$857K Buy
70,130
+895
+1% +$10.9K ﹤0.01% 2520
2022
Q3
$859K Sell
69,235
-148,627
-68% -$1.84M ﹤0.01% 2495
2022
Q2
$4.28M Buy
217,862
+24,573
+13% +$482K ﹤0.01% 1497
2022
Q1
$5.04M Sell
193,289
-791,994
-80% -$20.7M ﹤0.01% 1502
2021
Q4
$28M Buy
985,283
+25,223
+3% +$716K 0.02% 589
2021
Q3
$30.6M Buy
960,060
+90,909
+10% +$2.9M 0.03% 519
2021
Q2
$30.2M Sell
869,151
-227,481
-21% -$7.89M 0.03% 514
2021
Q1
$32.3M Buy
1,096,632
+88,881
+9% +$2.62M 0.03% 456
2020
Q4
$30.9M Buy
1,007,751
+271,085
+37% +$8.31M 0.03% 443
2020
Q3
$20.6M Buy
736,666
+220,665
+43% +$6.16M 0.03% 525
2020
Q2
$11.1M Sell
516,001
-52,993
-9% -$1.14M 0.01% 777
2020
Q1
$12.7M Buy
568,994
+195,428
+52% +$4.38M 0.02% 641
2019
Q4
$11M Buy
373,566
+45,207
+14% +$1.33M 0.01% 860
2019
Q3
$8.73M Buy
328,359
+126,124
+62% +$3.35M 0.01% 921
2019
Q2
$6.84M Buy
202,235
+5,210
+3% +$176K 0.01% 1064
2019
Q1
$6.32M Buy
197,025
+129,229
+191% +$4.14M 0.01% 1065
2018
Q4
$2.14M Buy
67,796
+7,407
+12% +$234K ﹤0.01% 1614
2018
Q3
$2.11M Buy
+60,389
New +$2.11M ﹤0.01% 1781